References
- Crowther MA, Burrows RF, Ginsberg J, Kelton JG, Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Rev 1996;10:8–16.
- Kelton JG. Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 2002;16:43–46. doi:10.1054/blre.2001.0181
- Provan D, Newland A, Idiopathic thrombocytopenic purpura in adults. J Pediatr Hematol Oncol 2003;25:S34–S38.
- Gill KK, Kelton JG, Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000;37:275–289.
- Sun D, Shehata N, Ye XY, Gregorovich S, De France B, Arnold DM et al. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood 2016;128:1329–1335. doi:10.1182/blood-2016-04-710285
- Wegnelius G. Bremme K and Lindqvist PG. Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticosteroids and intravenous immunoglobulin: a prospective follow-up of suggested practice. Blood Coagul Fibrinolysis 2018 Mar;29:141–147. doi:10.1097/MBC.0000000000000683
- Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood 2013 Jan;121:38–47. doi:10.1182/blood-2012-08-448944
- Koyama S, Tomimatsu T, Kanagawa T, Kumasawa K, Tsutsui T, Kimura T. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol 2012;87:15–21. doi:10.1002/ajh.v87.1
- Revolade EPAR product information.
- Nplate Prescribing information.
- Nplate: EPAR product information. https://www.ema.europa.eu/en/medicines/human/EPAR/nplate (May 2019)
- Patil AS,Dotters-Katz SK, Metjian AD, James AH, Swamy GK. Novel use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy. Obstet Gynecol 2013 Aug;122:483–485.13. doi:10.1097/AOG.0b013e31828d5b56
- Alkaabi JK, Alkindi S, Riyami NAl, Zia F, Balla LM, Balla SM. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus. Lupus 2012;21:1571–1574. doi:10.1177/0961203312463621
- Samuelson BT. Kreuziges LB and Gernsheimer T. Use of romiplostim for refractory primary immune thrombocytopenia during pregnancy. Clin Obstet Gynecol Reprod Med 2017;3:1–3. doi:10.15761/COGRM.1000172
- Decroocq J, Marcellin L, Le Ray C, Willems L. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. Obstet Gynecol 2014 Aug;124:481–483. doi:10.1097/AOG.0000000000000371
- Harrington P, Nelson-Piercy C, Williamson C, Cooper N, Kesse-Adu R, Robinson S. Refractory severe immune thrombocytopenia in a twin pregnancy. Obstet Med 2018 Mar;11:35–38. doi:10.1177/1753495X17709188
- Giermasz A, Knoche J. Tolerability and efficacy of romiplostim as management of severe refractory immune thrombocytopenia (ITP) during pregnancy. Thromb Haemost 2013;11: 75–75.
- Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol 2018;182:106–113. doi:10.1111/bjh.15280